Companies: 10,795·Total market cap: $144.5T
Cogent Biosciences, Inc.

Cogent Biosciences, Inc.

COGTNASDAQHealthcare● Active
$31.16
+$0.14(+0.45%)
Market Cap$5.3B
P/E Ratio
52W High$43.73
52W Low$5.485
Overview

Cogent Biosciences, Inc. (COGT) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · COGT · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-3.08cogt eps ttm · cogt earnings per shareEarnings history
PE Ratio (TTM)cogt pe ratio ttm · cogt price to earningsPE Ratio deep dive
Revenue (TTM)0.00cogt revenue ttm · cogt annual revenueFull revenue history
Dividend YieldNo Dividenddoes cogt pay dividends · cogt dividend yieldDividend history
Shares Outstanding67.6Mcogt shares outstanding · cogt floatShares outstanding history
Next EarningsAug 4, 2026Est.cogt earnings date · cogt next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
cogent biosciences, inc. revenue · cogt revenue 2025
FY 2025Net Income-$328.9M▼ 28.56% YoY
202320242025
cogent biosciences, inc. net income · cogt profit 2025
FY 2025EPS$-2.55▼ 3.66% YoY
202320242025
cogt eps · cogent biosciences, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$354.3MEPS: $-3.08View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy12 analystsis cogt a buy · cogt analyst rating
Strong Buy
0
Buy
10
Hold
2
Sell
0
Strong Sell
0
12-Month Price Target
$35.00Low
$31.16Current
$49.40Avg Target58.54% upside
$60.00High
cogt price target · cogt 12 month forecast

Total: 12 · Buy rate: 83.3%

The COGT analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $49.40, representing +58.54% upside from the current price of $31.16.

Stock Performance

Full History
1D-5.40%
1W-5.43%
1M-10.71%
3M-16.34%
YTD-12.67%
1Y+349.57%
5Y+295.16%

About Cogent Biosciences, Inc.

CEOAndrew R. Robbins
IPO DateMar 29, 2018
Employees205
CountryUS

Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted treatments for illnesses rooted in specific genetic anomalies. The company's primary therapeutic candidate is CGT9486, a…

what is cogent biosciences, inc. · cogt stock overview · cogent biosciences, inc. company profile · who is cogent biosciences, inc. ceo · cogt NASDAQ · cogent biosciences, inc. headquarters · cogent biosciences, inc. business segments

About Stock Overview & Key Data

Cogent Biosciences, Inc. (COGT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 29, 2018. As of the latest trading session, COGT stock price is $31.16, with a market capitalization of $5.3B. The stock has returned +349.57% over the past 12 months and -12.67% year-to-date.

According to 12 Wall Street analysts, the consensus rating for Cogent Biosciences, Inc. stock is Buy, with an average 12-month price target of $49.40. In fiscal year 2025, Cogent Biosciences, Inc. reported revenue of — and net income of -$328.9M. For detailed data — including Cogent Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Cogent Biosciences, Inc. (COGT) stock price is $31.16. The stock is traded on NASDAQ under the ticker symbol COGT. The 52-week range is $5.49 – $43.73.

COGT stock priceCOGT quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice